We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
ESC 2024 - Scott Solomon shares the results of the FINEARTS-HF trial, in which the efficacy of finerenone was examined in patients with HFmrEF/HFpEF. He says: "This offers clinicians a new option for the treatment of these patients with an enormous unmet need."
This video was recorded during the ESC Congress 2024 in London, UK.
Scott D. Solomon, MD is the Edward D. Frohlich Distinguished Chair, Professor of Medicine at Harvard Medical School and Senior Physician at Brigham and Women’s Hospital in Boston, MA, US. He directs the Cardiac Imaging Core Laboratory and the Clinical Trials Endpoints Center at Brigham and Women’s Hospital.
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Read our summary of FINEARTS-HF
Release date: 1 September 2024
ESC 2024 - Scott Solomon shares the results of the FINEARTS-HF trial, in which the efficacy of finerenone was examined in patients with HFmrEF/HFpEF. He says: "This offers clinicians a new option for the treatment of these patients with an enormous unmet need."
This video was recorded during the ESC Congress 2024 in London, UK.
Scott D. Solomon, MD is the Edward D. Frohlich Distinguished Chair, Professor of Medicine at Harvard Medical School and Senior Physician at Brigham and Women’s Hospital in Boston, MA, US. He directs the Cardiac Imaging Core Laboratory and the Clinical Trials Endpoints Center at Brigham and Women’s Hospital.
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Read our summary of FINEARTS-HF
Release date: 1 September 2024
Stay current with the best on medical education
